Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CBX5 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | ZNF345 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | RRM2B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | GBA | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | ZNF835 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | TIFAB | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | SAMSN1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | EMC7 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | PTGDR2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | ZNF606 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |